Ractigen

Provider of siRNA therapeutics to silence transcription repressors for the treatment of oncology, dermatology & single gene disorders

placeNantong, Jiangsu, China calendar_todayFounded 2015 language ractigen.com

Social engagement

Social engagement: 1K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

8 investors on record; lead investors include Hillhouse, SDIC.

Investor typeCountShare
Venture capital338%
Private equity338%
Bank & private debt113%
Other / undisclosed113%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

14 May 2026 · Scientist, Associate Director, Director – RNA Discovery & Development

10 Feb 2026 · Senior Manager, Clinical Pharmacology Director, Neuroscience Discovery, Vice President, Oligonucleotide Chemis

Based on job postings tracked across public sources.

Recent activity

19 Mar 2026
Milestone
regulatory
13 Jan 2026
Milestone
regulatory
12 Dec 2025
Milestone
regulatory
Coming soon